GGrantIndex
Sort

64,565 grants matching drug discovery

Joint genomic and statistical analyses of schizophrenia and bipolar to decipher genetic susceptibility

$746,636
Roel A Ophoff · University Of California Los Angeles · R01 · FY2020 · MH

Re-engineering gp120 to include glycan-dependent epitopes

$746,619
Phillip Berman · University Of California Santa Cruz · R01 · FY2015 · AI

Novel antibacterial agents derived from natural products

$746,516
Nigel D Priestley · Promiliad Biopharma, Inc. · R42 · FY2019 · AI

Molecular, Cellular, and Tissue Characterization Unit

$746,441
Joe W. Gray · Oregon Health & Science University · U2C · FY2021 · CA

Statistical Mechanics with Quantum Potentials: Application to Host-Gues

$746,434
Simon Webb · Verachem, Llc · R44 · FY2015 · GM

Structural bioinformatics software for epitope selection and antibody engineering

$746,428
Steven Joseph Darnell · Dnastar, Inc. · R44 · FY2014 · GM

Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis

$746,424
Afshin Dowlati · Case Western Reserve University · U01 · FY2011 · CA

Developing therapeutics to treat chronic infections

$746,404
Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2014 · AI

Development of novel isoflavone drugs as broad spectrum antivirals

$746,345
Kristin M Bedard · Kineta, Inc. · R44 · FY2017 · AI

Center for Humanized Mice

$746,325
Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2016 · OD

Lead Optimization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease

$746,325
Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2017 · AG

Development of dual effective kinase inhibitors as syndromic treatment of Giardiasis and Cryptosporidiosis

$746,285
Kayode K Ojo · University Of Washington · R01 · FY2025 · AI

Alzheimer's Disease Neuroimaging Initiative

$746,232
Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2020 · AG

A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans

$746,230
Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2019 · AT

Enhancing Discovery of HIV Host Genetics using Drug Abuse and other Interactions

$746,184
Eric O Johnson · Research Triangle Institute · R01 · FY2018 · DA

Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy

$746,147
Scott Matthew Ebert · Emmyon, Inc. · R44 · FY2018 · AG

Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy

$746,147
Scott Matthew Ebert · Emmyon, Inc. · R44 · FY2019 · AG

Project 2: Response to Treatment

$746,072
David R Sherman · Seattle Children'S Hospital · U19 · FY2022 · AI

A Scalable Platform to Discover Antimicrobials of Ribosomal Origin

$746,060
Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2019 · AI

Lead Optimization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease

$745,976
Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2018 · AG

Biophotonics

$745,889
George Patterson · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2019 · EB

3D-FACS: 3D image-based fluorescence activated cell sorting

$745,884
Sung Hwan Cho · Nanocellect Biomedical, Inc. · R44 · FY2020 · DA

HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease Progression

$745,882
Raymond T Chung · Massachusetts General Hospital · R01 · FY2014 · DK

(Epi)genetic Risk Architectures in Opioid Dependent Brain

$745,878
Peter Christopher Scacheri · Case Western Reserve University · R01 · FY2021 · DA

Scientific Core - Pharmaceutics and Midicinal Chemistry

$745,877
Patrick J. Sinko · Rbhs-Robert Wood Johnson Medical School · U54 · FY2016 · AR